Condition
CDK4/6 Inhibitors clinical trials and research
As of November 12, 2026, Find a Trial lists 2 CDK4/6 Inhibitors clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), China (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Predicting outcomes for advanced breast cancer patients treated with CDK4/6 inhibitors and endocrine therapy
This study is trying to see how well different CDK4/6 inhibitors combined with hormone therapy work for people with advanced breast cancer and how safe they are.
-
Combining CDK4/6 inhibitors with hormone therapy and what comes next for HR+/HER2- metastatic breast cancer
This study will see how different follow-up treatments work after progression on CDK4/6 inhibitors plus hormone therapy in people with HR+/HER2- metastatic breast cancer.
Related topics
Quick answers
How many CDK4/6 Inhibitors clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.